TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34647827

Group type: EXPERIMENTAL
Intervention: 10 cmH2O PEP during methacholine delivery
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 10 cmH2O PEP during the 3.5 min following methacholine delivery
Number of subjects: 18

Group type: COMPARATOR
Intervention: No PEP
Number of subjects: 18
Study: 32816096

Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention (aerobic exercise 5-6 times/week, resistance exercise 2-3 times/week, dietary intervention aiming for BMI of 25 kg/m2)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention
Number of subjects: 98

Group type: COMPARATOR
Intervention: Standard care (individual guidance on disease management, lifestyle advice, blinded regulation of medication)
Number of subjects: 98
Study: 35389424

Group type: EXPERIMENTAL
Intervention: HD201
Number of subjects: 0

Group type: COMPARATOR
Intervention: Referent Trastuzumab
Number of subjects: 0
Study: 32118823

Group type: EXPERIMENTAL
Intervention: Compensatory reserve measurement (CRM)
Number of subjects: 100
Study: 35286051

Group type: EXPERIMENTAL
Intervention: Moderate-Intensity Interval Exercise (MIE)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Moderate-Intensity Continuous Exercise (MCE)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Pre-exercise betatrophin levels
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Correlation with obesity markers
Number of subjects: 30
Study: 32848901

Group type: EXPERIMENTAL
Intervention: Process-based multi-task cognitive training
Number of subjects: 90

Group type: COMPARATOR
Intervention: Health education (Control)
Number of subjects: 90
Study: 35490877

Group type: EXPERIMENTAL
Intervention: Emotional memory reactivation electroconvulsive therapy (EMR-ECT)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control memory reactivation electroconvulsive therapy (CMR-ECT)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Both EMR-ECT and CMR-ECT
Number of subjects: 72
Study: 34243746

Group type: EXPERIMENTAL
Intervention: Coordinated support system (linking hospital outpatient physiotherapy services to a public health coaching service) with up to 10 telephone-based health coaching sessions over 6 months
Number of subjects: 374

Group type: COMPARATOR
Intervention: Usual care provided at discharge from treatment
Number of subjects: 374
Study: 36272055

Group type: EXPERIMENTAL
Intervention: Active theta tACS (6 Hz) on the medial prefrontal cortex (mPFC)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Sham theta tACS
Number of subjects: 16
Study: 33249492

Group type: EXPERIMENTAL
Intervention: Digital cognitive behavioral therapy for insomnia (dCBT‐I)
Number of subjects: 208

Group type: COMPARATOR
Intervention: Sleep education
Number of subjects: 208
Study: 32382745

Group type: EXPERIMENTAL
Intervention: Oral testosterone undecanoate (TU)
Number of subjects: 222

Group type: COMPARATOR
Intervention: Topical testosterone (Axiron)
Number of subjects: 222
Study: 36389184

Group type: EXPERIMENTAL
Intervention: Haptic feedback in VR training module
Number of subjects: 31

Group type: COMPARATOR
Intervention: Non-haptic group
Number of subjects: 31
Study: 33618922

Group type: EXPERIMENTAL
Intervention: saxagliptin 5 mg
Number of subjects: 24

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 24
Study: 34537125

Group type: EXPERIMENTAL
Intervention: Magnesium Sulfate (MSG)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Remifentanil (RG)
Number of subjects: 50
Study: 32202490

Group type: EXPERIMENTAL
Intervention: CRP POCT
Number of subjects: 653

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 653
Study: 32354432

Group type: EXPERIMENTAL
Intervention: Clear aligner therapy (CA)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Fixed appliance therapy (FA)
Number of subjects: 49
Study: 35225119

Group type: EXPERIMENTAL
Intervention: Mixed physical exercise protocol with dual task (DT) (30 sessions, 2x/week, duration of 60-90 min)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Standard physical exercise protocol without DT
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Mixed physical exercise under DT
Number of subjects: 26
Study: 36174028

Group type: EXPERIMENTAL
Intervention: Telemedicine management
Number of subjects: 120

Group type: COMPARATOR
Intervention: Conventional outpatient clinic appointment
Number of subjects: 120
Study: 33594388

Group type: EXPERIMENTAL
Intervention: rVSV-EBOV vaccine
Number of subjects: 300000
Study: 32391919

Group type: COMPARATOR
Intervention: Liposomal amphotericin B (LAmB) 3.0 mg/kg/d
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Intravenous itraconazole (ivITCZ) induction: 400 mg/d, maintenance: 200 mg/d
Number of subjects: 102
Study: 33486058

Group type: EXPERIMENTAL
Intervention: Dexamethasone (10 mg administered within 90 minutes of surgery)
Number of subjects: 75
Study: 35534456

Group type: EXPERIMENTAL
Intervention: Schema Therapy (ST)
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Therapy (CBT)
Number of subjects: 193
Study: 33740360

Group type: EXPERIMENTAL
Intervention: Opioids post-surgery
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Opioids for non-severe pain
Number of subjects: 200

Group type: COMPARATOR
Intervention: Black patients
Number of subjects: 200

Group type: COMPARATOR
Intervention: Intra- and post-operative opioid administration
Number of subjects: 200
Study: 32453449

Group type: EXPERIMENTAL
Intervention: Collaborative Care (CC)
Number of subjects: 214

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 214

Group type: COMPARATOR
Intervention: Non-receipt of Care (NC)
Number of subjects: 214
Study: 36186981

Group type: EXPERIMENTAL
Intervention: IntraCoronary Artery Retrograde Thrombolysis (ICART)
Number of subjects: 286

Group type: COMPARATOR
Intervention: Thrombus aspiration or PTCA
Number of subjects: 286
Study: 32564482

Group type: EXPERIMENTAL
Intervention: Telephone counselling (TC)
Number of subjects: 1446

Group type: COMPARATOR
Intervention: No telephone counselling (Control)
Number of subjects: 1446
Study: 35608484

Group type: EXPERIMENTAL
Intervention: Liberal approach to glucose control (intravenous insulin commenced at blood glucose >252 mg/dL, titrated to 180-252 mg/dL)
Number of subjects: 419

Group type: COMPARATOR
Intervention: Comparator approach to glucose control (insulin commenced at blood glucose >180 mg/dL, titrated to 108-180 mg/dL)
Number of subjects: 419
Study: 32917508

Group type: EXPERIMENTAL
Intervention: Guided imagery
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 32516094

Group type: EXPERIMENTAL
Intervention: Individual Load-Velocity Profiling (ILVP)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Group Load-Velocity Profiling (GLVP)
Number of subjects: 19
Study: 35321961

Group type: EXPERIMENTAL
Intervention: One-piece SIMOs
Number of subjects: 24

Group type: COMPARATOR
Intervention: Two-piece SIMOs
Number of subjects: 24
Study: 35115706

Group type: EXPERIMENTAL
Intervention: H2HA-Ferritin 20-μg dose (n=5)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: H2HA-Ferritin 60-μg dose in homologous prime-boost regimen (n=25)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: H2HA-Ferritin 60-μg dose in heterologous prime-boost regimen (n=20)
Number of subjects: 50

Group type: COMPARATOR
Intervention: H2 DNA vaccine (control group, n=5)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: H2HA-Ferritin vaccine
Number of subjects: 50
Study: 32060708

Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33596116

Group type: EXPERIMENTAL
Intervention: Taperloc stem
Number of subjects: 38

Group type: COMPARATOR
Intervention: Mallory-Head stem
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Both stems
Number of subjects: 38
Study: 32722793

Group type: EXPERIMENTAL
Intervention: 20 U incobotulinumtoxinA
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: 60 U incobotulinumtoxinA
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: 100 U incobotulinumtoxinA
Number of subjects: 38
Study: 32146109

Group type: EXPERIMENTAL
Intervention: Restricted group (n=291); instructed to refrain from hip flexion >90°, adduction across midline, and internal rotation for 6 weeks.
Number of subjects: 587

Group type: COMPARATOR
Intervention: Unrestricted group (n=294); no specific restrictions on hip movement.
Number of subjects: 587

Group type: COMPARATOR
Intervention: Unrestricted group (n=294); no restrictions.
Number of subjects: 587
Study: 35666982

Group type: EXPERIMENTAL
Intervention: CTC-high patients
Number of subjects: 401

Group type: COMPARATOR
Intervention: CTC-low patients
Number of subjects: 401
Study: 32310156

Group type: EXPERIMENTAL
Intervention: Dry needling
Number of subjects: 25
Study: 33279544

Group type: EXPERIMENTAL
Intervention: Vicryl mesh coverage after thoracoscopic bullectomy
Number of subjects: 204

Group type: COMPARATOR
Intervention: Control group (no Vicryl mesh)
Number of subjects: 204
Study: 32349779

Group type: EXPERIMENTAL
Intervention: CEOP/IVE/GDP
Number of subjects: 106

Group type: COMPARATOR
Intervention: CEOP
Number of subjects: 106
Study: 33331126

Group type: EXPERIMENTAL
Intervention: 8888 group (8 hours time-in-bed each night)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: 8888 group
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: 8846 group (variable sleep schedule)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: 8486 group (variable sleep schedule)
Number of subjects: 78

Group type: COMPARATOR
Intervention: 8666 group (stable sleep schedule)
Number of subjects: 78

Group type: COMPARATOR
Intervention: 8846 group (stable sleep schedule)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: 8486 group
Number of subjects: 78

Group type: COMPARATOR
Intervention: 8666 group
Number of subjects: 78

Group type: COMPARATOR
Intervention: 8846 group
Number of subjects: 78
Study: 33470281

Group type: EXPERIMENTAL
Intervention: Intravitreal injection alone
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: ETDRS panretinal photocoagulation combined with intravitreal ranibizumab
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: PASCAL panretinal photocoagulation combined with intravitreal ranibizumab
Number of subjects: 30

Group type: COMPARATOR
Intervention: ETDRS group
Number of subjects: 30

Group type: COMPARATOR
Intervention: PASCAL group
Number of subjects: 30
Study: 35100493

Group type: EXPERIMENTAL
Intervention: LC hair essence serum (1 ml diluted with 0.5 ml of 0.9% normal saline, injected once weekly for 8 weeks)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Botulinum toxin A (50 units injected)
Number of subjects: 62
Study: 34880029

Group type: EXPERIMENTAL
Intervention: phacotrabeculectomy
Number of subjects: 124

Group type: COMPARATOR
Intervention: phacogoniotomy
Number of subjects: 124
Study: 36085410

Group type: EXPERIMENTAL
Intervention: EndoRings (ER)
Number of subjects: 556

Group type: COMPARATOR
Intervention: Standard Colonoscopy (SC)
Number of subjects: 556
Study: 32007239

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine infusion at a rate of 0.4 μg kg‐1 h‐1 for 24 h
Number of subjects: 108

Group type: COMPARATOR
Intervention: Saline infusion
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 108

Group type: COMPARATOR
Intervention: Saline control
Number of subjects: 108
Study: 35568917

Group type: EXPERIMENTAL
Intervention: True APP therapy
Number of subjects: 206

Group type: COMPARATOR
Intervention: Sham point stimulation therapy
Number of subjects: 206
Study: 33546647

Group type: EXPERIMENTAL
Intervention: Peer-led exercise and education Positive Living programme (PL programme)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Therapeutic relationship (TR)
Number of subjects: 49
Study: 35872936

Group type: EXPERIMENTAL
Intervention: CT imaging big data‐assisted arterial chemoembolization combined with 125I seed implantation
Number of subjects: 116

Group type: COMPARATOR
Intervention: Arterial chemoembolization alone with gemcitabine combined with cisplatin (GP)
Number of subjects: 116
Study: 34270979

Group type: EXPERIMENTAL
Intervention: Home-based intervention for postpartum contraception
Number of subjects: 234

Group type: COMPARATOR
Intervention: Control clusters (no home-based intervention)
Number of subjects: 234

Group type: EXPERIMENTAL
Intervention: Home-based intervention
Number of subjects: 234
Study: 35726852

Group type: EXPERIMENTAL
Intervention: Exercise group with beetroot juice supplement (EX&BRJS)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (C)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Exercise group (EX)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Beetroot juice supplement group (BRJS)
Number of subjects: 40
Study: 34476663

Group type: EXPERIMENTAL
Intervention: Generic drugs
Number of subjects: 125
Study: 32167605

Group type: EXPERIMENTAL
Intervention: 14-day reverse hybrid therapy (dexlansoprazole 60 mg o.d. plus amoxicillin 1 g b.d. for 14 days, and clarithromycin 500 mg plus metronidazole 500 mg b.d. for initial 7 days)
Number of subjects: 248

Group type: COMPARATOR
Intervention: 14-day concomitant therapy (dexlansoprazole 60 mg o.d. plus amoxicillin 1 g, clarithromycin 500 mg, and metronidazole 500 mg b.d. for 14 days)
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: 14-day reverse hybrid therapy
Number of subjects: 248

Group type: COMPARATOR
Intervention: 14-day concomitant therapy
Number of subjects: 248
Study: 35551624

Group type: EXPERIMENTAL
Intervention: E-learning for postural education (4 sessions via web-based Student Education Network, SHAD)
Number of subjects: 408

Group type: COMPARATOR
Intervention: Control group (no intervention specified)
Number of subjects: 408

Group type: EXPERIMENTAL
Intervention: E-learning for postural education
Number of subjects: 408
Study: 34149019

Group type: EXPERIMENTAL
Intervention: Spanish version of the Prolapse and Incontinence Knowledge Questionnaire (PIKQ)
Number of subjects: 57
Study: 32093647

Group type: EXPERIMENTAL
Intervention: Self-efficacy improvement programme (SIP) consisting of 1 day of theory and 4 weeks of practice
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 66
Study: 36450821

Group type: EXPERIMENTAL
Intervention: Vuse Solo Original
Number of subjects: 0

Group type: COMPARATOR
Intervention: Abstinence
Number of subjects: 0
Study: 34612106

Group type: EXPERIMENTAL
Intervention: 2Q‐AF test
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: 2Q‐AF score
Number of subjects: 56

Group type: COMPARATOR
Intervention: �2.00 DS lens flippers
Number of subjects: 56
Study: 36328392

Group type: EXPERIMENTAL
Intervention: Communicating community protection for friends and family
Number of subjects: 512

Group type: EXPERIMENTAL
Intervention: Communicating community protection for overall society
Number of subjects: 512

Group type: EXPERIMENTAL
Intervention: Communicating community protection for friends and family among white participants
Number of subjects: 512

Group type: EXPERIMENTAL
Intervention: Communicating community protection for overall society among white participants
Number of subjects: 512

Group type: EXPERIMENTAL
Intervention: Communicating community protection for friends and family among ethnically diverse participants
Number of subjects: 512

Group type: EXPERIMENTAL
Intervention: Communicating community protection for overall society among ethnically diverse participants
Number of subjects: 512
Study: 33840495

Group type: EXPERIMENTAL
Intervention: Relaxation group (listened to a prerecorded relaxation breathing session before and during the injection)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Control group (received the injection without a relaxation session)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Relaxation group
Number of subjects: 104
Study: 35872933

Group type: EXPERIMENTAL
Intervention: Combined examination (CDUS, MAM, CA153)
Number of subjects: 10821

Group type: COMPARATOR
Intervention: CDUS
Number of subjects: 10821

Group type: COMPARATOR
Intervention: MAM
Number of subjects: 10821

Group type: COMPARATOR
Intervention: CA153
Number of subjects: 10821
Study: 32431306

Group type: EXPERIMENTAL
Intervention: Student peer evaluations
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Student self-evaluations
Number of subjects: 100

Group type: COMPARATOR
Intervention: Faculty evaluations
Number of subjects: 100
Study: 33804788

Group type: EXPERIMENTAL
Intervention: HPV vaccination status
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Age and marital status
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Provider endorsement
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Race/ethnicity, religion, skills, intention to counsel parents
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Intentions to counsel parents on HPV vaccination
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Interventions to improve vaccination rates
Number of subjects: 153
Study: 35486013

Group type: EXPERIMENTAL
Intervention: Acupuncture combined with moxibustion (acu-mox)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Medication group (ioratadine tablets, 1 tablet daily for 10 days, 3 sessions)
Number of subjects: 80
Study: 33243286

Group type: EXPERIMENTAL
Intervention: tDCS (2 mA for 20 min) with working memory training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham stimulation with working memory training
Number of subjects: 0
Study: 34299780

Group type: EXPERIMENTAL
Intervention: Low-calorie diet with meat product (LCD + MP)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Low-calorie diet (LCD)
Number of subjects: 36
Study: 32014686

Group type: EXPERIMENTAL
Intervention: High-dose systemic interferon-α2b (HDI) following dendritic cell (DC) vaccination
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dendritic cell (DC) vaccination alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High-dose systemic interferon-α2b (HDI)
Number of subjects: 0
Study: 35654568

Group type: EXPERIMENTAL
Intervention: 4EO mouthrinse
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Professional flossing (FBH)
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Supervised self-flossing (FUS)
Number of subjects: 156

Group type: COMPARATOR
Intervention: Negative control (NC)
Number of subjects: 156
Study: 32542695

Group type: EXPERIMENTAL
Intervention: Zoledronic acid
Number of subjects: 76

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study: 32028480

Group type: EXPERIMENTAL
Intervention: Electroabrasion treatment on half of the wound
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control (untreated half of the wound)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Electroabrasion treatment
Number of subjects: 24
Study: 36452984

Group type: EXPERIMENTAL
Intervention: Big blades with Randall foils
Number of subjects: 20

Group type: COMPARATOR
Intervention: Big blades without Randall foils
Number of subjects: 20
Study: 33802272

Group type: EXPERIMENTAL
Intervention: Curcumin (Curcuma longa)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Boswellia (Boswellia serrata)
Number of subjects: 20

Group type: COMPARATOR
Intervention: French Maritime Pine Bark (Pinus pinaster)
Number of subjects: 20
Study: 35960394

Group type: EXPERIMENTAL
Intervention: HNC Virtual Coach
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard clinical care and paper logs
Number of subjects: 0
Study: 33954839

Group type: EXPERIMENTAL
Intervention: High-flow nasal therapy (HFNT)
Number of subjects: 1852

Group type: COMPARATOR
Intervention: Low-flow oxygen (LFO)
Number of subjects: 1852

Group type: COMPARATOR
Intervention: Permissive hypoxaemia
Number of subjects: 1852

Group type: COMPARATOR
Intervention: Liberal vs permissive comparison
Number of subjects: 1852

Group type: COMPARATOR
Intervention: HFNT vs LFO comparison
Number of subjects: 1852

Group type: COMPARATOR
Intervention: Strata-specific 28 day mortality rates
Number of subjects: 1852

Group type: EXPERIMENTAL
Intervention: Neurocognitive sequelae
Number of subjects: 1852
Study: 35634695

Group type: EXPERIMENTAL
Intervention: Multispecies probiotic containing Lactobacillus rhamnosus HN001™, Lactobacillus paracasei Lpc‐37®, and Bifidobacterium animalis subsp lactis HN019™
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Multispecies probiotic
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 34972869

Group type: EXPERIMENTAL
Intervention: Integrated dual-task training (IDTT) for 8 weeks
Number of subjects: 58

Group type: COMPARATOR
Intervention: Consecutive dual-task training (CDTT) for 8 weeks
Number of subjects: 58
Study: 33570801

Group type: EXPERIMENTAL
Intervention: Verbal counselling plus audio feedback (ordinary Clip-tone®)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Verbal counselling plus audio and visual feedback (Clip-tone® with smartphone application)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Verbal counselling only
Number of subjects: 200

Group type: COMPARATOR
Intervention: Verbal counselling with resistance (modified Clip-tone®)
Number of subjects: 200
Study: 32731259

Group type: EXPERIMENTAL
Intervention: Zanubrutinib
Number of subjects: 201

Group type: COMPARATOR
Intervention: Ibrutinib
Number of subjects: 201
Study: 34768124

Group type: EXPERIMENTAL
Intervention: HIV clinic‐based buprenorphine (BUP/NX)
Number of subjects: 264

Group type: COMPARATOR
Intervention: Methadone maintenance therapy (MMT)
Number of subjects: 264
Study: 34456060

Group type: EXPERIMENTAL
Intervention: Intranasal varenicline 0.12 mg in OC‐01 nasal spray
Number of subjects: 22

Group type: COMPARATOR
Intervention: Oral varenicline 1 mg
Number of subjects: 22
Study: 35019018

Group type: EXPERIMENTAL
Intervention: Aesthetic pre-evaluative temporary technique (group A)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Traditional technique (group T)
Number of subjects: 6
Study: 36380332

Group type: EXPERIMENTAL
Intervention: Targeted hypothermia (33 °C)
Number of subjects: 1592

Group type: COMPARATOR
Intervention: Normothermia with early treatment of fever (body temperature, ≥37.8 °C)
Number of subjects: 1592
Study: 33386046

Group type: EXPERIMENTAL
Intervention: Sensor-based motor rehabilitation (12 sessions, 40 minutes, 3 times a week for 4 weeks)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Conventional therapy (12 sessions, 40 minutes, 3 times a week for 4 weeks)
Number of subjects: 37
Study: 33582788

Group type: EXPERIMENTAL
Intervention: Radio ads
Number of subjects: 568

Group type: EXPERIMENTAL
Intervention: TV interviews
Number of subjects: 568

Group type: EXPERIMENTAL
Intervention: Social media posts
Number of subjects: 568

Group type: EXPERIMENTAL
Intervention: Community events
Number of subjects: 568

Group type: EXPERIMENTAL
Intervention: Personal referrals
Number of subjects: 568